United States
Germany
Japan
United Kingdom
China
Anti-CD19 Reference Antibody (Loncastuximab tesirine)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Products
Anti-CD19 Reference Antibody (Loncastuximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-CD19 Reference Antibody (denintuzumab-MMAF)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-CD19 Reference Antibody (tafasitamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus, Macaque |
Anti-CD19 Reference Antibody (denintuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-CD19 Reference Antibody (inebilizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
Anti-CD19 Reference Antibody (Duke U. patent anti-CD19)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-CD19 Reference Antibody (Immunomedics hA19)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-CD19 Reference Antibody (obexelimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus, Macaque |
Anti-CD19 Reference Antibody (coltuximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
